Deodhar, A <br/><br/>
Denosumab-mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients.  [electronic resource] 

 -  Arthritis care & research  Apr 2010 
 - 569-74 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2151-4658 
<br/><br/><label>Standard No.: </label>10.1002/acr.20004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Arthritis, Rheumatoid--complications<br/>Bone Density--drug effects<br/>Bone Resorption--etiology<br/>Denosumab<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Hypodermoclysis<br/>Male<br/>Middle Aged<br/>RANK Ligand--administration & dosage